Amgen (AMGN)
(Delayed Data from NSDQ)
$325.39 USD
+2.66 (0.82%)
Updated Aug 15, 2024 04:00 PM ET
Pre-Market: $323.00 -2.39 (-0.73%) 8:20 AM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Product Sales: Prolia: Total
- 4,048.00
- 3,628.00
- 3,248.00
- 2,763.00
- 2,672.00
- Revenue - Line of Business (LOBR)
- Product Sales: Repatha: Total
- 1,635.00
- 1,296.00
- 1,117.00
- 887.00
- 661.00
- Revenue - Line of Business (LOBR)
- Product Sales: Parsabiv: Total
- 362.00
- 382.00
- 280.00
- 716.00
- 630.00
- Revenue - Line of Business (LOBR)
- Product Sales: KYPROLIS: Total
- 1,403.00
- 1,247.00
- 1,108.00
- 1,065.00
- 1,044.00
- Revenue - Line of Business (LOBR)
- Product Sales: XGEVA: Total
- 2,112.00
- 2,014.00
- 2,018.00
- 1,899.00
- 1,935.00
- Revenue - Line of Business (LOBR)
- Product Sales: Vectibix: Total
- 984.00
- 893.00
- 873.00
- 811.00
- 744.00
- Revenue - Line of Business (LOBR)
- Product Sales: Nplate: Total
- 1,477.00
- 1,307.00
- 1,027.00
- 850.00
- 795.00
- Revenue - Line of Business (LOBR)
- Product Sales: BLINCYTO: Total
- 861.00
- 583.00
- 472.00
- 379.00
- 312.00
- Revenue - Line of Business (LOBR)
- Product Sales: Enbrel: Total
- 3,697.00
- 4,117.00
- 4,465.00
- 4,996.00
- 5,226.00
- Revenue - Line of Business (LOBR)
- Product Sales: LUMAKRAS/LUMYKRAS: Total
- 280.00
- 285.00
- 90.00
- 0.00
- --
- Revenue - Line of Business (LOBR)
- Revenue: Product sales
- 26,910.00
- 24,801.00
- 24,297.00
- 24,240.00
- 22,204.00
- Revenue - Line of Business (LOBR)
- Product Sales: AMJEVITA/AMGEVITA: Total
- 626.00
- 460.00
- 439.00
- 331.00
- 215.00
- Revenue - Line of Business (LOBR)
- Product Sales: Neulasta: Total
- 848.00
- 1,126.00
- 1,734.00
- 2,293.00
- 3,221.00
- Revenue - Line of Business (LOBR)
- Revenue: Product: TAVNEOS: Total
- 134.00
- 21.00
- 0.00
- --
- --
- Revenue - Line of Business (LOBR)
- Product Sales: Aranesp: Total
- 1,362.00
- 1,421.00
- 1,480.00
- 1,568.00
- 1,729.00
- Revenue - Line of Business (LOBR)
- Product Sales: EVENITY: Total
- 1,160.00
- 787.00
- 530.00
- 350.00
- 189.00
- Revenue - Line of Business (LOBR)
- Revenue: Other revenues
- 1,280.00
- 1,522.00
- 1,682.00
- 1,184.00
- 1,158.00
- Revenue - Line of Business (LOBR)
- Product Sales: MVASI: Total
- 800.00
- 901.00
- 1,166.00
- 798.00
- 127.00
- Revenue - Line of Business (LOBR)
- Product Sales: Aimovig: Total
- 323.00
- 414.00
- 317.00
- 378.00
- 306.00
- Revenue - Line of Business (LOBR)
- Product Sales: Other products: Total
- 709.00
- 431.00
- 339.00
- 283.00
- 312.00
- Revenue - Line of Business (LOBR)
- Product Sales: Otezla: Total
- 2,188.00
- 2,288.00
- 2,249.00
- 2,195.00
- 178.00
- Revenue - Line of Business (LOBR)
- Product Sales: TEZSPIRE: Total
- 567.00
- 170.00
- 0.00
- --
- --
- Revenue - Line of Business (LOBR)
- Product Sales: EPOGEN: Total
- 226.00
- 506.00
- 521.00
- 598.00
- 867.00
- Revenue - Geographic (GEOR)
- Product Sales: Prolia: US
- 2,733.00
- 2,465.00
- 2,150.00
- 1,830.00
- 1,772.00
- Revenue - Geographic (GEOR)
- Product Sales: Prolia: ROW
- 1,315.00
- 1,163.00
- 1,098.00
- 933.00
- 900.00
- Revenue - Geographic (GEOR)
- Product Sales: Repatha: US
- 793.00
- 608.00
- 557.00
- 459.00
- 376.00
- Revenue - Geographic (GEOR)
- Product Sales: Repatha: ROW
- 842.00
- 688.00
- 560.00
- 428.00
- 285.00
- Revenue - Geographic (GEOR)
- Product Sales: Parsabiv: US
- 228.00
- 253.00
- 150.00
- 605.00
- 550.00
- Revenue - Geographic (GEOR)
- Product Sales: Parsabiv: ROW
- 134.00
- 129.00
- 130.00
- 111.00
- 80.00
- Revenue - Geographic (GEOR)
- Product Sales: KYPROLIS: US
- 921.00
- 850.00
- 736.00
- 710.00
- 654.00
- Revenue - Geographic (GEOR)
- Product Sales: KYPROLIS: ROW
- 482.00
- 397.00
- 372.00
- 355.00
- 390.00
- Revenue - Geographic (GEOR)
- Product Sales: XGEVA: US
- 1,527.00
- 1,480.00
- 1,434.00
- 1,405.00
- 1,457.00
- Revenue - Geographic (GEOR)
- Product Sales: XGEVA: ROW
- 585.00
- 534.00
- 584.00
- 494.00
- 478.00
- Revenue - Geographic (GEOR)
- Product Sales: Vectibix: US
- 461.00
- 396.00
- 347.00
- 342.00
- 316.00
- Revenue - Geographic (GEOR)
- Product Sales: EVENITY: ROW
- 351.00
- 254.00
- 199.00
- 159.00
- 147.00
- Revenue - Geographic (GEOR)
- Revenue: Product: Other: US
- 549.00
- 393.00
- 202.00
- 109.00
- 105.00
- Revenue - Geographic (GEOR)
- Revenue: Product: Other: International
- 160.00
- 246.00
- 137.00
- 174.00
- 207.00
- Revenue - Geographic (GEOR)
- Product Sales: EPOGEN: US
- 226.00
- 506.00
- 521.00
- 598.00
- 867.00
- Revenue - Geographic (GEOR)
- Product Sales: Nplate: US
- 996.00
- 848.00
- 566.00
- 485.00
- 480.00
- Revenue - Geographic (GEOR)
- Product Sales: Nplate: ROW
- 481.00
- 459.00
- 461.00
- 365.00
- 315.00
- Revenue - Geographic (GEOR)
- Revenue: Product: International
- 7,638.00
- 7,058.00
- 7,011.00
- 6,255.00
- 5,673.00
- Revenue - Geographic (GEOR)
- Revenue: Product: US
- 19,272.00
- 17,743.00
- 17,286.00
- 17,985.00
- 16,531.00
- Revenue - Geographic (GEOR)
- Product Sales: Otezla: US
- 1,777.00
- 1,886.00
- 1,804.00
- 1,790.00
- 139.00
- Revenue - Geographic (GEOR)
- Product Sales: Otezla: ROW
- 411.00
- 402.00
- 445.00
- 405.00
- 39.00
- Revenue - Geographic (GEOR)
- Product Sales: MVASI: US
- 511.00
- 602.00
- 826.00
- 656.00
- 121.00
- Revenue - Geographic (GEOR)
- Product Sales: MVASI: ROW
- 289.00
- 299.00
- 340.00
- 142.00
- 6.00
- Revenue - Geographic (GEOR)
- Product Sales: AMJEVITA/AMGEVITA: US
- 126.00
- 0.00
- 0.00
- 0.00
- 0.00
- Revenue - Geographic (GEOR)
- Product Sales: AMJEVITA/AMGEVITA: ROW
- 500.00
- 460.00
- 439.00
- 331.00
- 215.00
- Revenue - Geographic (GEOR)
- Product Sales: LUMAKRAS/LUMYKRAS: US
- 197.00
- 222.00
- 82.00
- --
- --
- Revenue - Geographic (GEOR)
- Product Sales: LUMAKRAS/LUMYKRAS: ROW
- 83.00
- 63.00
- 8.00
- --
- --
- Revenue - Geographic (GEOR)
- Revenue: Product: TAVNEOS: US
- 126.00
- 16.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Revenue: Product: TAVNEOS: ROW
- 8.00
- 5.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Product Sales: Aranesp: US
- 452.00
- 521.00
- 537.00
- 629.00
- 758.00
- Revenue - Geographic (GEOR)
- Product Sales: Aranesp: ROW
- 910.00
- 900.00
- 943.00
- 939.00
- 971.00
- Revenue - Geographic (GEOR)
- Product Sales: Enbrel: US
- 3,650.00
- 4,044.00
- 4,352.00
- 4,855.00
- 5,050.00
- Revenue - Geographic (GEOR)
- Product Sales: Enbrel: ROW
- 47.00
- 73.00
- 113.00
- 141.00
- 176.00
- Revenue - Geographic (GEOR)
- Product Sales: Neulasta: US
- 710.00
- 959.00
- 1,514.00
- 2,001.00
- 2,814.00
- Revenue - Geographic (GEOR)
- Product Sales: Neulasta: ROW
- 138.00
- 167.00
- 220.00
- 292.00
- 407.00
- Revenue - Geographic (GEOR)
- Product Sales: BLINCYTO: US
- 566.00
- 336.00
- 278.00
- 231.00
- 176.00
- Revenue - Geographic (GEOR)
- Product Sales: BLINCYTO: ROW
- 295.00
- 247.00
- 194.00
- 148.00
- 136.00
- Revenue - Geographic (GEOR)
- Product Sales: Aimovig: US
- 303.00
- 398.00
- 313.00
- 378.00
- 306.00
- Revenue - Geographic (GEOR)
- Product Sales: Aimovig: ROW
- 20.00
- 16.00
- 4.00
- 0.00
- 0.00
- Revenue - Geographic (GEOR)
- Product Sales: EVENITY: US
- 809.00
- 533.00
- 331.00
- 191.00
- 42.00
- Revenue - Geographic (GEOR)
- Product Sales: Vectibix: ROW
- 523.00
- 497.00
- 526.00
- 469.00
- 428.00